High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction
- 1 November 1993
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 67 (5) , 237-244
- https://doi.org/10.1007/bf01715054
Abstract
The fibrinolytic capacity of blood depends mainly on the amount of tissue-type plasminogen activator (t-PA) activity and plasminogen activator inhibitor type-1 (PAI-1) activity. Previous studies linked high PAI activity or low t-PA activity with the development of atherosclerosis and thromboembolic diseases. Yet, there are conflicting reports in the literature as to whether there is higher PAI activity in patients with myocardial infarction (MI) than in patients with coronary artery disease (CAD) without previous MI. In this retrospective study, t-PA activity, t-PA antigen, and PAI activity before and after a venous occlusion test (VOT) of 10 min were assessed in 109 patients with angiographically documented CAD, in two subgroups of CAD patients with (n=66) or without (n=43) previous MI, and in subgroups of CAD patients according to their triglyceride levels and other risk factors. The mean values of t-PA activity in the whole patient group showed a 100-fold increase and a 3.1-fold increase in t-PA antigen after VOT (0.03±0.03 to 3.0±6.8 U/ml and 16.5±6.9 to 51.0±25.4 ng/ml,p25 U/ml) was found. This subgroup of patients represented the highest PAI activity after VOT (pp ppppp pp<0.001). No differences were found between subgroups of CAD patients separated according to smoking habits, blood pressure, cholesterol, and severity of CAD. This study confirms former findings of elevated PAI activity in patients with coronary artery disease. In contrast to some reports, it did not demonstrate a difference between patients with and without previous MI. Further studies may clarify whether changes in lipid metabolism influence the function of endothelial cells in synthesis or secretion of PAI. Prospective studies are necessary to determine whether high PAI activity is a risk factor for the development of coronary artery disease or MI.Keywords
This publication has 57 references indexed in Scilit:
- Hypertriglyceridemia and regulation of fibrinolytic activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Increased Plasminogen Activator Inhibitor Activity in Survivors of Myocardial Infarction Is Associated with Metabolic Risk Factors of AtherosclerosisPathophysiology of Haemostasis and Thrombosis, 1992
- Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemiaAmerican Heart Journal, 1990
- Interrelationship between coagulant activity and tissue‐type plasminogen activator (t‐PA) system in acute ischaemic heart disease. Possible role of the endotheliumJournal of Internal Medicine, 1990
- Impaired fibrinolysis in coronary artery diseaseAmerican Heart Journal, 1988
- Severity of Coronary Artery Disease and Basal FibrinolysisPathophysiology of Haemostasis and Thrombosis, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- HAEMOSTATIC FACTORS IN HUMAN AORTIC INTIMAThe Lancet, 1981
- FIBRINOLYTIC ACTIVITY AND CORONARY-ARTERY DISEASEThe Lancet, 1968